Carl Icahn is trying to engineer a sale of Amylin Pharmaceuticals to pharma giant Eli Lilly and Co., according to a report today by Reuters. Lilly is already partnering with Amylin on its diabetes drug Byetta.
Carl Icahn is trying to engineer a sale of Amylin Pharmaceuticals to pharma giant Eli Lilly and Co., according to a report today by Reuters. Lilly is already partnering with Amylin on its diabetes drug Byetta.